Recruiting NCT03949049
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Citicoline, Placebo.
- Who it may be relevant to
- Registry conditions: Neonatal Hypoxia. Basic parameters: up to 1 months · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Efficacy of Citicoline as Neuroprotector in Neonates Exposed to Hypoxia: A Randomized Controlled Trial
Overview
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Detailed description
Efficacy of Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Interventions
- Drug Citicoline
Citacoline as neuroprotector - Other Placebo
placebo group
Primary outcome measures
- number of seizures [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- neonates with hypoxia.
Exclusion criteria
- hypoxic ischemic encephalopathy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Sherief Abd-Elsalam — Cairo
Publications
- Salamah A, El Amrousy D, Elsheikh M, Mehrez M. Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial. Ital J Pediatr. 2023 May 12;49(1):55. doi: 10.1186/s13052-023-01452-5. PMID 37173784
Identifiers
NCT: NCT03949049 · neonates tanta